CYP3A4 and metabolic dysfunction-associated steatotic liver disease: Furthermore, and in agreement with a previous study in patients with NAFLD and obesity [5], we observed a weak inverse correlation between NAFLD liver fat score and 4βOHC concentrations, suggesting decreased CYP3A4 activity in patients with NAFLD.